UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells

The Journal of immunology (1950), 2018-07, Vol.201 (1), p.264-277

2018

Volltextzugriff (PDF)

The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (6), p.djw283

2017

Volltextzugriff (PDF)

JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer

Oncoimmunology, 2017-03, Vol.6 (3), p.e1291106-e1291106

2017

Volltextzugriff (PDF)

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation

Cancers, 2020-11, Vol.12 (11), p.3379

2020

Volltextzugriff (PDF)

The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells

Oncoimmunology, 2016-12, Vol.5 (12), p.e1247135-e1247135

2016

Volltextzugriff (PDF)

5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL + Cytotoxic T Lymphocyte Cytotoxicity

Cancers, 2023-03, Vol.15 (5), p.1563

2023

Volltextzugriff (PDF)

UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development

PLoS genetics, 2015-11, Vol.11 (11), p.e1005643-e1005643

2015

Volltextzugriff (PDF)

DDRGK1, a crucial player of ufmylation system, is indispensable for autophagic degradation by regulating lysosomal function

Cell death & disease, 2021-04, Vol.12 (5), p.416-416, Article 416

2021

Volltextzugriff (PDF)

Targeting translation: eIF4E as an emerging anticancer drug target

Expert reviews in molecular medicine, 2016-01, Vol.18, p.e2-e146; e38; e5223; e81669; e24849, Article e2

2016

Volltextzugriff (PDF)

The Wdr5-H3K4me3 Epigenetic Axis Regulates Pancreatic Tumor Immunogenicity and Immune Suppression

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8773

2024

Volltextzugriff (PDF)

H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth

Oncogene, 2022-04, Vol.41 (18), p.2651-2662

2022

Volltextzugriff (PDF)

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

Journal for immunotherapy of cancer, 2019-06, Vol.7 (1), p.157-11, Article 157

2019

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis

Cell reports (Cambridge), 2018-12, Vol.25 (11), p.3036-3046.e6

2018

Volltextzugriff (PDF)

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance

Frontiers in oncology, 2023-09, Vol.13, p.1286790-1286790

2023

Volltextzugriff (PDF)

WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002624

2021

Volltextzugriff (PDF)

Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells

BMC cancer, 2018-02, Vol.18 (1), p.149-149, Article 149

2018

Volltextzugriff (PDF)

Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells

Cancer Immunology, Immunotherapy, 2020-11, Vol.69 (11), p.2233-2245

2020

Volltextzugriff (PDF)

Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression

Cancers, 2021-02, Vol.13 (5), p.1006

2021

Volltextzugriff (PDF)

The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins

The Journal of biological chemistry, 2014-03, Vol.289 (13), p.8947-8959

2014

Volltextzugriff (PDF)

Type I Interferon Activates PD-1 Expression through Activation of the STAT1-IRF2 Pathway in Myeloid Cells

Cells (Basel, Switzerland), 2024-07, Vol.13 (13), p.1163

2024

Volltextzugriff (PDF)

Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation

Cell discovery, 2019-01, Vol.5 (1), p.7-7, Article 7

2019

Volltextzugriff (PDF)

Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo

Cancers, 2022-01, Vol.14 (2), p.361

2022

Volltextzugriff (PDF)

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003543

2022

Volltextzugriff (PDF)

p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e001365

2020

Volltextzugriff (PDF)

H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells

Oncoimmunology, 2018-09, Vol.7 (9), p.e1483302-e1483302

2018

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells

The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion

JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation

The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells

5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL + Cytotoxic T Lymphocyte Cytotoxicity

UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development

DDRGK1, a crucial player of ufmylation system, is indispensable for autophagic degradation by regulating lysosomal function

Targeting translation: eIF4E as an emerging anticancer drug target

The Wdr5-H3K4me3 Epigenetic Axis Regulates Pancreatic Tumor Immunogenicity and Immune Suppression

H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance

WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape

Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells

Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells

Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression

The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins

Type I Interferon Activates PD-1 Expression through Activation of the STAT1-IRF2 Pathway in Myeloid Cells

Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation

Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy

H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells

Suchergebnisse filtern